Skip to main content

Table 6 Comparison of treatment factors in patients with stage IV disease

From: The clinicopathological features of colorectal mucinous adenocarcinoma and a therapeutic strategy for the disease

Treatment factors NMA MA P-value
  (n = 349) (n = 28)  
Curability of first surgery    0.353
   Complete 96 (27.5%) 10 (35.7%)  
   Incomplete 253 (72.5%) 18 (64.3%)  
Regimen of first chemotherapy    0.362
   OXA-based 25 (7.1%) 3 (10.7%)  
   IRI-based 18 (5.1%) 3 (10.7%)  
   5-FU intravenously 43 (12.3%) 4 (14.2%)  
   5-FU orally 36 (10.3%) 4 (14.2%)  
Additional resection    
   Liver resection 75 (21.4%) 3 (10.7%) 0.228
   Lung resection 10 (2.8%) 0 (0.0%) 1.000
  1. OXA, oxaliplatin; IRI, irinotecan; 5-FU, 5-fluolouracil; NMA, non-mucinous adenocarcinoma; MA, mucinous adenocarcinoma.
\